ADPT Adaptive Biotechnologies Corpor
$24.20▼ -0.12%
Healthcare
Other
After hours
$23.38▼ -3.39%
Sep 11, 7:30 PM ET
Volume 1.24M
Avg Volume (10D) 1.60M
Key Metrics & Fundamentals
Market Cap
$3.86B
P/E Ratio
–
Div Yield
–%
52W Range
12.00 - 26.87
% vs 50 MA
2.19%
% vs 200 MA
35.58%
RSI-14
47.7
MACD Histogram
-0.2700
Beta (1Y vs SPY)
1.79
Free Cash Flow
-$7.58M
Gross Rev
$71.55M
Gross Profit
$51.39M
EBITDA
-$9.82M
COGS
$20.17M
Operating Exp
$67.16M
Operating Income
-$15.77M
EBIT
-$15.77M
Pretax Income
-$39.94M
Net Income
-$39.79M
EPS (Diluted)
-0.25
Price & Volume History
Loading chart…
Recent News
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Sep 1, 2026 8:05 PM
What Is Really Moving Tempus AI Stock Right Now?
Trefis · Aug 24, 2026 6:23 PM
Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next.
Barchart · Aug 21, 2026 2:55 PM
Adaptive Biotechnologies Insider Sold Shares Worth $3,135,850, According to a Recent SEC Filing
MT Newswires · Aug 20, 2026 7:37 AM
Adaptive Biotechnologies Q2 Loss Widens, Revenue Rise
MT Newswires · Jul 30, 2026 8:29 AM
Adaptive Biotechnologies Corp (ADPT) (Q2 2026) Earnings Call Highlights: MRD Revenue Surges ...
GuruFocus.com · Jul 30, 2026 5:03 AM
Adaptive Biotechnologies (ADPT) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks · Jul 29, 2026 11:00 PM
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Jul 29, 2026 10:25 PM
Adaptive Biotechnologies Q2 Earnings Call Highlights
MarketBeat · Jul 29, 2026 10:03 PM
Adaptive Biotechnologies: Q2 Earnings Snapshot
Associated Press · Jul 29, 2026 8:41 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ADPT's money flow as a full page
Social Sentiment
No Reddit posts found for ADPT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.